This morning, UBS lowered its price target on shares of Newfield Exploration (NYSE:NFX) to $28 as oil production will be less than original expected through 2016. In the report, UBS reduced its EPS estimates and maintained its neutral rating. Shares of Newfield were lower by 0.3% today.
Wells Fargo downgraded shares of Edwards Lifescience (NYSE:EW) from outperform to market perform as competition is increasing domestically. Shares of Edwards Lifescience were also lower by 0.3% today.
And Bank of America downgraded shares of Quest Diagnostics (NYSE:DGX) to an underperform rating as growth is expected to be slow throughout 2014. In the report, Bank of America set a $55 price target. Shares of Quest Diagnostics were lower by 3.4% on the news.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.